Facebook
Twitter
Telegram
Report an ErrorAlexion Pharmaceuticals, Inc. Balance Sheet 2011-2024 | ALXN
Annual Balance Sheet Alexion Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-402 M | -184 M | 1.48 B | 2.3 B | 2.09 B | 2.45 B | -886 M | -417 M | -841 M | -539 M |
Long Term Debt |
2.42 B | 2.38 B | 2.5 B | 2.72 B | 2.89 B | 3.28 B | 9.5 M | 65 M | 101 M | - |
Total Non Current Liabilities |
4.83 B | 5.08 B | 3.59 B | 3.74 B | 3.74 B | 4.16 B | 293 M | 353 M | 283 M | 30 M |
Total Current Liabilities |
1.62 B | 1.19 B | 1.17 B | 952 M | 823 M | 718 M | 607 M | 582 M | 360 M | 230 M |
Total Liabilities |
6.45 B | 6.27 B | 4.77 B | 4.69 B | 4.56 B | 4.87 B | 900 M | 936 M | 643 M | 260 M |
Deferred Revenue |
- | - | - | 15.9 M | 37 M | 20.5 M | 58.8 M | 53.8 M | 31.3 M | 18.8 M |
Retained Earnings |
5.24 B | 4.64 B | 2.33 B | 2.24 B | 1.82 B | 1.18 B | 1.04 B | 379 M | 126 M | -129 M |
Total Assets |
18.1 B | 17.5 B | 13.9 B | 13.6 B | 13.3 B | 13.1 B | 4.2 B | 3.32 B | 2.61 B | 1.39 B |
All numbers in USD currency